Dr Reddys
USFDA seeks voluntary action at Dr Reddy's Andhra Pradesh facility
Diabetes to be our focus in India, US: Wockhardt's Habil Khorakiwala
New launches, regulatory go-ahead key triggers for Dr Reddy's
Top headlines: Air India's 100% stake sale; 1,000 frauds in 5 years at UCBs
Stock recommendation from Prabhudas Lilladher: Buy Dr Reddy's, GAIL

Dr Reddy's falls 5% as rival firm beats Co to US FDA approval for EluRyng
Technical calls by Religare Broking: Buy Dr Reddy's Lab, Ramco Cements
Dr Reddy's gets 4 observations from USFDA for Srikakulam plant
Dr Reddy's Laboratories recalls anti-ulcer drug ranitidine from US market
Dr Reddy's Labs shines among pharma stocks, wins investor confidence

Dr Reddy's halts worldwide supply of Ranitidine drug after probe by USFDA
Regulatory worries, price erosion may pull down Dr Reddy's US revenues
Dr Reddy's Labs slumps 8% as US FDA issues CRL for its version of NuvaRing
Dr Reddy's launches insomnia treatment tablets in US after FDA approval
Dr Reddy's closes sale of US, select territory rights for neurology drugs
Dr Reddy's Laboratories unveils generic version of Allegra-D in US